Invest in Quantitative Trading
Two ways to invest with us, depending on your profile and goals.
Trading Participation
Invest capital, we trade it with our live strategies. You benefit from our expertise without managing it yourself.
| Invested Amount | Mgmt Fee | Perf Fee |
|---|---|---|
| 10 000 - 49 999 EUR | 2.0% | 20% |
| 50 000 - 99 999 EUR | 1.5% | 18% |
| 100 000 - 249 999 EUR | 1.0% | 15% |
| 250 000+ EUR | 0.5% | 12% |
- Detailed monthly reporting
- Legal structure: SEP (Société en Participation, Belgian law)
- Withdrawal: 30 days notice
- High-water mark on performance fee
Early investors: priority access to new strategies upon validation. Fixed terms -- the tier obtained today remains valid.
Strategy Acquisition
Starting from 300 000 EUR
For investors who wish to operate themselves: buy a strategy with exclusivity.
- Starting from 300,000 EUR per strategy
- Deliverable: complete logic, optimized parameters, assistance with production deployment
- Exclusivity: the strategy is no longer sold after acquisition
- Immediate availability: TSM V4 (Trend)
- CarryArb and PCA StatArb: available after validation (~4 months R&D each)
Funding R&D
We have one strategy in live production and two in advanced validation phase. Each strategy requires about 4 months of research, testing, and optimization to be ready for live.
Your investment directly funds the talent and infrastructure needed to validate the carry and mean reversion strategies. In return, you are the first to benefit -- with the best conditions.
Quantitative Talent
Recruitment and compensation of specialized researchers.
Infrastructure
Backtesting, tick-by-tick data, 24/7 monitoring.
Validation
Walk-Forward Optimization, Monte Carlo, stress tests.
Deployment
Production deployment with continuous supervision.
24 strategies tested and rejected
Out of dozens of developed strategies, the majority were classified as unprofitable after thorough research. Each validated strategy has survived months of Walk-Forward Optimization, Monte Carlo simulations, and stress tests.
We publish our failures -- it is the hallmark of a rigorous scientific process. The strategies that survive this filter have a statistically significant edge.
Let's discuss your investment
Schedule a meeting for a confidential discussion about your investment goals.
Past performance is not indicative of future results. The results presented are derived from backtests and do not constitute a guarantee of returns. This document does not constitute investment advice.